Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
  • A61K8/04—Dispersions; Emulsions
  • A61K8/042—Gels
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
  • A61K8/04—Dispersions; Emulsions
  • A61K8/06—Emulsions
  • A61K8/062—Oil-in-water emulsions
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
  • A61K8/04—Dispersions; Emulsions
  • A61K8/06—Emulsions
  • A61K8/068—Microemulsions
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
  • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
  • A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K9/00—Medicinal preparations characterised by special physical form
  • A61K9/10—Dispersions; Emulsions
  • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
  • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
  • A61Q15/00—Anti-perspirants or body deodorants

Definitions

• the present invention relates to oil-in-water type microemulsions, processes for their preparation and their use for cosmetic purposes.
• the present invention relates to the use of microemulsions according to the invention for medical purposes, in particular as medicament carriers for lipophilic active substances and their pharmaceutical use as topical dermatics, but also for the parenteral administration of pharmaceutical active substances and for parenteral nutrition.
• Cosmetic skin care is primarily to be understood to mean that the natural function of the skin as a barrier against environmental influences (eg dirt, chemicals, microorganisms) and against the loss of the body's own substances (eg water, natural fats, electrolytes) is strengthened or restored .
• environmental influences eg dirt, chemicals, microorganisms
• loss of the body's own substances eg water, natural fats, electrolytes
• the aim of skin care is also to compensate for the loss of fat and water in the skin caused by daily washing. This is especially important when the natural regeneration ability is insufficient.
• skin care products are intended to protect against environmental influences, in particular from the sun and wind, and to delay skin aging.
• Medical compositions usually contain one or more drugs in effective concentration.
• drugs in effective concentration.
• a clear distinction is made between cosmetic and medical use and corresponding products on the the legal provisions of the Federal Republic of Germany (e.g. Cosmetics Ordinance, Food and Drug Law).
• the droplet diameter of transparent or translucent microemulsions dage ⁇ gene is in the range of about 10 -2 microns to about 10 "1 micron. Such microemulsions are mostly of low viscosity. The viscosity of many microemulsions of the O / W type is comparable with that of water.
• microemulsions are that active substances can be more finely dispersed in the disperse phase than in the disperse phase of "macroemulsions". Another advantage is that they can be sprayed on account of their low viscosity. If microemulsions are used as cosmetics, corresponding ones are distinguished Products characterized by high cosmetic elegance.
• a disadvantage of the microemulsions of the prior art is that a high content of one or more emulsifiers must always be used, since the small droplet size causes a high interface between the phases, which generally has to be stabilized by emulsifiers. - 3 -
• the present invention relates to special embodiments of cosmetic and dermatological light protection preparations, in particular skin care cosmetic and dermatological light protection preparations.
• UVC range rays with a wavelength shorter than 290 nm
• UVB range rays in the range between 290 nm and 320 nm, the so-called UVB range, cause erythema simple sunburn or even more or less severe burns.
• the narrower range around 308 nm is given as a maximum of the erythema effectiveness of sunlight.
• UVA range It is also important to have filter substances available for the range between about 320 nm and about 400 nm, the so-called UVA range, since their rays can also cause damage. It has been shown that UVA radiation leads to damage to the elastic and collagen fibers of the connective tissue, which causes the skin to age prematurely, and that it can be seen as the cause of numerous phototoxic and photoallergic reactions. The damaging influence of UVB radiation can be increased by UVA radiation. However, UV radiation can also lead to photochemical reactions, in which case the photochemical reaction products interfere with the skin's metabolism.
• antioxidants and / or free radical scavengers can be incorporated into the cosmetic or dermatological formulations.
• UV absorbers or UV reflectors are most inorganic pigments which are known to be used in cosmetics to protect the skin from UV rays. These are oxides of titanium, zinc, iron, zirconium, silicon, manganese, aluminum, cerium and mixtures thereof, as well as modifications.
• microemulsions are also suitable for other cosmetic dermatological applications, for example deodorants, so that the present invention relates in a particular embodiment to microemulsions as the basis for cosmetic deodorants.
• Cosmetic deodorants are used to eliminate body odor that arises when the fresh, odorless sweat is decomposed by microorganisms.
• the usual cosmetic deodorants are based on different active principles.
• astringents predominantly aluminum salts such as aluminum hydroxychloride (aluminum chlorohydrate).
• the bacterial flora on the skin can be reduced.
• only the odor-causing microorganisms should be effectively reduced.
• the sweat flow itself is not affected by this, in the ideal case only the microbial decomposition of the sweat is temporarily stopped.
• Deodorants should meet the following conditions: 1) They should cause reliable deodorization.
• liquid deodorants for example aerosol sprays, roll-ons and the like
• solid preparations for example deodorant sticks ("sticks"), powder, powder sprays, intimate cleansing agents, etc. are known and customary.
• microemulsions as the basis for deodorant or antiperspirant preparations is also known.
• Their relatively high content of emulsifiers, with the disadvantages described, has hitherto been a problem that has to be remedied.
• a further object of the present invention was therefore to develop preparations which are suitable as a basis for cosmetic deodorants or antiperspirants and which do not have the disadvantages of the prior art.
• preparation forms such as cleaning emulsions, face and body care preparations, but also extremely medicinal-pharmaceutical dosage forms, for example preparations against acne and other skin symptoms, should be created.
• the invention therefore relates to cleansing emulsions, in particular facial cleansing emulsions, preferably makeup removers, for example eye makeup removers.
• cleansing emulsions in particular facial cleansing emulsions, preferably makeup removers, for example eye makeup removers.
• makeup removers for example eye makeup removers.
• Such preparations are known per se. These are usually mixtures of cosmetic oils or aqueous preparations of surface-active substances, the function of which is to solubilize the contamination or the make-up body and to remove it from the skin.
• Waterproof eye make-up for example mascara
• make-up removers on an aqueous basis using special surfactants.
• these surfactants often have only limited physiological tolerance. When such substances come into contact with the mucous membrane, in particular the mucous membrane of the eyes, these substances lead to irritation, which manifests itself, for example, in reddening of the eyes. Reactions of this type are typical of surfactant-containing products.
• An object of the present invention was therefore to remedy such problems.
• the present invention relates to hair cosmetic preparations.
• the present invention relates to hair cosmetic preparations for the care of the hair and the scalp.
• the present invention relates to preparations which serve to strengthen the individual hair and / or to give the hair style overall hold and fullness.
• human hair can be divided into the living part, the hair root, and the dead part, the hair shaft.
• the hair shaft in turn consists of the medulla, which, due to developmental history, has become insignificant and receded for modern humans and is often completely absent with thin hair, furthermore the cortex surrounding the medulla and the cuticle surrounding the whole of the medulla and cortex.
• the cuticle in particular, but also the keratinous area between the cuticle and cortex as the outer covering of the hair, are particularly exposed to environmental influences, by combing and brushing, but also by hair treatment, in particular hair coloring and hair shaping, e.g. Perm method, exposed.
• the inside of the hair can also be affected.
• oxidants such as hydrogen peroxide
• the dye chromophore is formed by reacting precursors (phenols, aminophenols, more rarely also diamines) and bases (mostly p-phenylenediamine) with the oxidizing agent, usually hydrogen peroxide. Hydrogen peroxide concentrations of around 6% are usually used.
• the hydrogen peroxide also has a bleaching effect.
• oxidatively colored human hair similar to bleached hair, microscopic holes can be detected at the places where melamine granules were present.
• the oxidizing agent hydrogen peroxide not only reacts with the color precursors, but also with the hair substance and can cause damage to the hair.
• washing the hair with aggressive surfactants can also stress the hair, at least reduce its appearance or the appearance of the hairstyle overall.
• certain water-soluble hair components e.g. urea, uric acid, xanthine, keratin, glycogen, citric acid, lactic acid
• hair care cosmetics have been used for some time, which are intended to be rinsed out of the hair again after exposure, and some which are intended to remain on the hair.
• the latter can be formulated in such a way that they not only serve to care for the individual hair, but also improve the overall appearance of the hairstyle, for example by giving the hair more volume, fixing the hairstyle over a longer period of time, or its Improve manageability.
• the combability of the hair can be decisively improved by quaternary ammonium compounds. Such connections are drawn onto the hair and are often still detectable on the hair after several washes.
• a particular object of the present invention was to provide finely dispersed oil-in-water preparations with the lowest possible emulsifier content, which do not have the disadvantages of the prior art and which are suitable for a wide variety of cosmetic and / or dermatological applications, for example, can find the uses described above.
• Another object of the invention was to enrich the limited supply of finely dispersed oil-in-water preparations of the prior art.
• hydrophilic emulsifiers in particular polyethoxylated and polypropylene emulsifiers, change their solubility behavior from water-soluble to fat-soluble as the temperature rises.
• a characteristic of the hydrophilicity of a given emulator is its HLB value.
• Emulsifiers with HLB values of 6-8 are generally W / O emulsifiers, those with HLB values of 8-18 are generally O / W emulsifiers.
• phase inversion temperature range The temperature range in which the emulsifiers change their solubility is called the phase inversion temperature range.
• PIT phase inversion temperature range
• microemulsions produced in this way can be practically transparent at high temperature, for example in PIT, but become opaque again when they drop to room temperature.
• Microemulsions of the oil-in-water type comprising an oil phase which is essentially composed of non-volatile constituents and a water phase comprising: one or more polyethoxylated O / W emulsifiers and / or one or more polypropoxylated O / W emulsifiers and / or one or more polyethoxylated and polypropoxylated O / W emulsifiers, if desired further comprising one or more W / O emulsifiers having an emulsifier content of less than 20% by weight, based on the total weight of the emulsion, obtainable in such a way that a Mixture of the basic components, comprising water phase, oil phase, one or more of the O / W emulsifiers according to the invention, if desired one or more W / O emulsifiers, and, if desired, further auxiliaries, additives and / or active ingredients to a temperature within or brings above the phase inversion temperature range, and
• Microemulsions according to the invention have a low viscosity, are sprayable, are particularly suitable as vehicles for a wide variety of active ingredients, in particular lipid-soluble active ingredients, and are furthermore distinguished by excellent skin and mucous membrane compatibility.
• JP-A-Hei-06/262060 (according to Patent Abstracts of Japan) describes a solubilized preparation which can comprise, for example, polyethylene glycol alkyl ether.
• the oil phase of the disclosed examples relates to the volatile heptane, which is commonly hardly considered an oil component, and certainly not a cosmetic or pharmaceutical oil component.
• the microemulsions produced according to this teaching cannot be regarded as cosmetics or pharmaceuticals, despite the claim presented.
• the polyethoxylated or polypropoxylated or polyethoxylated and polypropoxylated O / W emulsifier or the polyethoxylated or polypropoxylated or polyethoxylated and polypropoxylated O / W emulsifiers are advantageously selected from the group of fatty alcohol ethoxylates of the general formula RO - (- CH 2 -CH 2 -O-) n -H, where R is a branched or unbranched alkyl, aryl or alkenyl radical and n is a number from 10 to 50 of the ethoxylated wool wax alcohols, the polyethylene glycol ethers of the general formula RO- (-CH 2 -CH 2 -O-) n -R ', where R and R' independently of one another are branched or unbranched alkyl or alkenyl radicals and n is a number from 10 to 80 of the fatty acid ethoxylates of the general formula
• R and R' independently of one another are branched or unbranched alkyl or alkenyl radicals and n is a number from 10 to 80, the Polyethylene glycol glycerol fatty acid esters of saturated and / or unsaturated, branched and / or unbranched fatty acids and a degree of ethoxylation between 3 and 50, the ethoxylated sorbitan esters with a degree of ethoxylation of 3 to 100 of the cholesterol ethoxylates with a degree of ethoxylation between 3 and 50, the ethoxylated triglycerides with a degree of ethoxylation between 3 and 150, the alkyl ether carboxylic acids of the general formula
• RO - (- CH 2 -CH 2 -O-) n -CH 2 -COOH or their cosmetically or pharmaceutically acceptable salts where R is a branched or unbranched alkyl or alkenyl radical having 5 to 30 carbon atoms and n is one Represent a number from 5 to 30, the polyoxyethylene sorbitol fatty acid ester, based on branched or unbranched alkanoic or alkenoic acids and having a degree of ethoxylation of 5 to 100, for example of the sorbeth type, the alkyl ether sulfates or the acids of the general formula RO - (- CH 2 - CH 2 -O-) n -SO 3 -H with cosmetically or pharmaceutically acceptable cations, where R is a branched or unbranched alkyl or alkenyl radical having 5 to 30 carbon atoms and n is a number from 1 to 50, the fatty alcohol propoxylates the general formula
• RO - (- CH 2 -CH (CH 3 ) -O-) n -R ' where R and R' independently of one another are branched or unbranched alkyl or alkenyl radicals and n is a number from 10 to 80 of the propoxylated wool wax alcohols, the etherified ones Fatty acid propoxylates of the general formula
• R-COO - (- CH 2 -CH (CH 3 ) -O-) n -R ' where R and R' independently of one another are branched or unbranched alkyl or alkenyl radicals and n is a number from 10 to 80 of the esterified fatty acid propoxylates the general formula
• R-COO - (- CH 2 -CH (CH 3 ) -O-) n -C (O) -R ' where R and R' independently of one another are branched or unbranched alkyl or alkenyl radicals and n is a number of 10 represent to 80, the fatty acid propoxylates of the general formula
• R-COO - (- CH 2 -CH (CH 3 ) -O-) n -H where R is a branched or unbranched alkyl or alkenyl radical and n is a number from 10 to 80, the polypropylene glycol glycerol fatty acid esters of saturated and / or unsaturated, branched and / or unbranched fatty acids and a degree of propoxylation between 3 and 80 of the propoxylated sorbitan esters with a degree of propoxylation of 3 to 100 of the cholesterol propoxylates with a degree of propoxylation of 3 to 100 of the propoxylated triglycerides with a degree of propoxylation of 3 to 100 of the alkyl ether carboxylic acids of the general formula
• RO - (- CH 2 -CH (CH 3 ) O-) n -CH 2 -COOH or their cosmetically or pharmaceutically acceptable salts where R is a branched or unbranched alkyl or alkenyl radical and n is a number from 3 to 50, the alkyl ether sulfates or the acids on which these sulfates are based, of the general formula RO - (- CH 2 -CH (CH 3 ) -O-) n -SO 3 -H with cosmetically or pharmaceutically acceptable cations, where R is a branched or unbranched alkyl - Or alkenyl radical with 5 - 30 carbon atoms and n represent a number from 1 to 50, the fatty alcohol ethoxylates / propoxylates of the general formula
• ROX n -Y m -H where R is a branched or unbranched alkyl or alkenyl radical, where X and Y are not identical and each represent either an oxyethylene group or an oxypropylene group and n and m independently of one another are numbers from 5 to 50, the polypropylene glycol ether of the general formula
• RO-Xn-Ym-R ' where R and R' independently of one another represent branched or unbranched alkyl or alkenyl radicals, where X and Y are not identical and in each case either an oxyethylene group or an oxypropylene group and n and m, independently of one another, numbers from 5 to 100 represent the etherified fatty acid propoxylates of the general formula
• R-COO-Xn-Ym-R ' where R and R' independently of one another represent branched or unbranched alkyl or alkenyl radicals, where X and Y are not identical and in each case either an oxyethylene group or an oxypropylene group and n and m independently of one another Numbers from 5 to 100 represent the fatty acid ethoxylates / propoxylates of the general formula
• R-COO-X n -Y m -H where R is a branched or unbranched alkyl or alkenyl radical, where X and Y are not identical and each have either an oxyethylene group or an oxypropylene group and n and m, independently of one another, numbers from 5 to 50 represent.
• the polyethoxylated or polypropoxylated or polyethoxylated and polypropoxylated O / W emulsifier or the polyethoxylated or polyprooxylated or polyethoxylated and polypropoxylated O / W emulsifiers is or are selected from the group of fatty alcohol ethoxylates general formula RO - (- CH 2 -CH 2 -O-) n -H, where R is a branched or unbranched alkyl or alkenyl radical having 5 to 30 carbon atoms and n is a number from 10 to 25 of the ethoxylated wool wax alcohols with HLB -Values from 1 1 - 16, very particularly advantageous with with HLB values from 14.5 - 15.5.
• R and R ' independently of one another are branched or unbranched alkyl or alkenyl radicals having 5 to 30 carbon atoms and n is a number from 10 to 50 of the esterified fatty acid ethoxylates of the general formula
• R-COO - (- CH 2 -CH 2 -O-) n -C (O) -R ' where R and R' independently of one another are branched or unbranched alkyl or alkenyl radicals having 5 to 30 carbon atoms and n is a number represent from 10 to 50, the polyethylene glycol glycerol fatty acid esters of saturated and / or unsaturated, branched and / or unbranched fatty acids having 6 to 26 carbon atoms and a degree of ethoxylation between 3 and 40 of the ethoxylated sorbitan esters with a degree of ethoxylation of 3 to 30 of the cholesterol ethoxylates with HLB values of 1 1 - 16, very particularly advantageous with HLB values of 14.5 - 15.5 of the ethoxylated triglycerides with HLB values of 11 - 16, very particularly advantageous with with HLB values of 14.5 - 15.5 of the alkyl ether carboxylic acids of the general formula
• RO - (- CH 2 -CH 2 -O-) ⁇ -CH 2 -COOH or their cosmetically or pharmaceutically acceptable salts where R is a branched or unbranched alkyl or alkenyl radical with 5-30 carbon atoms and n is one Representing a number from 10 to 20, the polyoxyethylene sorbitol fatty acid ester based on branched or unbranched alkanoic or alkenoic acids and having a degree of ethoxylation of 10 to 80, for example of the sorbeth type, the alkyl ether sulfates or the acids of the general formula on which these sulfates are based RO - (- CH 2 -CH 2 -O-) n -SO 3 -H with cosmetically or pharmaceutically acceptable cations, where R is a branched or unbranched alkyl or alkenyl radical having 5 to 30 carbon atoms and n is a number of 3 to 30 represent the fatty alcohol propoxylates of the
• RO - (- CH 2 -CH (CH 3 ) -O-) n -R ' where R and R' independently of one another are branched or unbranched alkyl or alkenyl radicals having 5 to 30 carbon atoms and n is a number from 10 to 40 represent the propoxylated wool wax alcohols with HLB values of 11-16, very particularly advantageously with HLB values of 14.5-15.5, the fatty acid propoxylates of the general formula
• R-COO - (- CH 2 -CH (CH 3 ) -O-) n -R ' where R and R' independently of one another are branched or unbranched alkyl or alkenyl radicals having 5 to 30 carbon atoms and n is a number of 10 to 30 represent the esterified fatty acid propoxylates of the general formula
• R and R * independently of one another are branched or unbranched alkyl or alkenyl radicals with 5-30 C- Atoms and n represent a number from 10 to 50, the polypropylene glycol glycerol fatty acid esters of saturated and / or unsaturated, branched and / or unbranched fatty acids with 6 to 26 carbon atoms and a degree of propoxylation between 3 and 50 of the propoxylated sorbitan esters with a degree of propoxylation of 3 to 80 of the cholesterol propoxylates with HLB values from 11 to 16, very particularly advantageously with with HLB values from 14.5 to 15.5 of the propoxylated triglycerides with HLB values from 11 to 16, very particularly advantageously with with HLB values from 14.5 to 15.5 of the alkyl ether carboxylic acids of the general formula
• RO - (- CH 2 -CH (CH 3 ) O-) n-CH 2 -COOH or their cosmetically or pharmaceutically acceptable salts where R is a branched or unbranched alkyl or alkenyl radical having 5 to 30 carbon atoms and n is a Represent a number from 10 to 30, the alkyl ether sulfates or the acids on which these sulfates are based, of the general formula RO - (- CH 2 -CH (CH 3 ) -O-) n -SO 3 -H with cosmetically or pharmaceutically acceptable cations, where R is a branched or unbranched alkyl or alkenyl radical having 5 to 30 carbon atoms and n is a number from 1 to 30.
• the polyethoxylated or polypropoxylated or polyethoxylated and polypropoxylated O / W emulsifiers used are particularly advantageously selected from the group of substances with HLB values of 11-16, very particularly advantageously with HLB values of 14.5- 15.5 if the O / W emulsifiers have saturated radicals R and R '. If the O / W emulsifiers have unsaturated radicals R and / or R ', or if isoalkyl derivatives are present, the preferred HLB value of such emulsifiers can also be lower or higher.
• fatty alcohol ethoxylates from the group of the ethoxylated stearyl alcohols, cetyl alcohols, cetylstearyl alcohols (cetearyl alcohols).
• cetyl alcohols cetylstearyl alcohols
• cetearyl alcohols cetearyl alcohols
• Polyethylene glycol (12) lauryl ether (Laureth-12), polyethylene glycol (12) isolauryl ether (Isolureth-12).
• the sodium laureth-11 carboxylate can advantageously be used as the ethoxylated alkyl ether carboxylic acid or its salt.
• Sodium laureth 1-4 sulfate can advantageously be used as alkyl ether sulfate.
• Polyethylene glycol (30) cholesteryl ether can advantageously be used as the ethoxylated cholesterol derivative.
• Polyethylene glycol (25) soyasterol has also proven itself.
• polyethylene glycol glycerol fatty acid esters from the group polyethylene glycol (20) glyceryl laurate, polyethylene glycol (21) glyceryl laurate, polyethylene glycol (22) glyceryl laurate, polyethylene glycol (23) glyceryl laurate, polyethylene glycol (6) glyceryl caprolate / caprinate 20) glyceryl oleate, polyethylene glycol (20) glyceryl isostearate, polyethylene glycol (18) glyceryl oleate / cocoat to choose.
• polyethylene glycol (20) glyceryl laurate polyethylene glycol (21) glyceryl laurate
• polyethylene glycol (22) glyceryl laurate polyethylene glycol (23) glyceryl laurate
• polyethylene glycol (20) glyceryl isostearate
• sorbitan esters from the group consisting of polyethylene glycol (20) sorbitan monolaurate, polyethylene glycol (20) sorbitan monostearate, polyethylene glycol (20) sorbitan monoisostearate, polyethylene glycol (20) sorbitan monopalmitate, polyethylene glycol (20) sorbitan monooleate.
• Optional W / O emulsifiers which are nevertheless advantageous according to the invention are: fatty alcohols with 8 to 30 carbon atoms, monoglycerol esters of saturated and / or unsaturated, branched and / or unbranched alkane carboxylic acids with a chain length of 8 to 24, in particular 12-18 C- Atoms, diglycerol esters of saturated and / or unsaturated, branched and / or unbranched alkane carboxylic acids with a chain length of 8 to 24, in particular 12-18 C atoms, monoglycerol ethers of saturated and / or unsaturated, branched and / or unbranched alcohols with a chain length of 8 to 24, in particular 12-18 C atoms, diglycerol ethers of saturated and / or unsaturated, branched and / or unbranched alcohols with a chain length of 8 to 24, in particular 12-18 C atoms, propylene glycol esters of saturated and / or unsaturated, branched and
• W / O emulsifiers are glyceryl monostearate, glyceryl monoisostearate, glyceryl monomyristate, glyceryl monooleate, diglyceryl monostearate, diglyceryl mono- isostearate, propylene glycol monostearate, propylene glycol monoisostearate, Propylenglycolmo- nocaprylat, sorbitan monoisostearate, sorbitan monolaurate, sorbitan bitanmonocaprylat propylene glycol monolaurate, Sorbitanmonoisooleat, sucrose distearate, cetyl alcohol, stearyl alcohol, arachidyl alcohol, behenyl alcohol, Isobehenylalkohol, selachyl alcohol, chimyl alcohol, polyethylene glycol (2) stearyl ether (steareth-2) , Glyceryl monolaurate, glyceryl monocaprinate
• the total content of emulsifiers less than 15% by weight, based on the total weight of the microemulsion. It is preferred to keep the total emulsifier content less than 10% by weight, in particular less than 8% by weight, based on the total weight of the microemulsion.
• the oil phase of the microemulsions according to the invention is advantageously selected from the group of the esters from saturated and / or unsaturated, branched and / or unbranched alkane carboxylic acids with a chain length of 3 to 30 carbon atoms and saturated and / or unsaturated, branched and / or unbranched alcohols a chain length of 3 to 30 carbon atoms, from the group of esters of aromatic carboxylic acids and saturated and / or unsaturated, branched and / or unbranched alcohols, a chain length of 3 to 30 carbon atoms.
• ester oils can then advantageously be selected from the group of isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl oleate, n-butyl stearate, n-hexyl laurate, n-decyl oleate, isooctyl stearate, isononyl stearate, isononyl isononanoate, 2-ethylhexyl ethylhexyl palate 2-octyldo ⁇ ecyl palmitate, oleyl oleate, olerlerucate, erucyl oleate, erucylerucate as well as synthetic, semi-synthetic and natural mixtures of such esters, for example Jojoba oil.
• the oil phase can advantageously be selected from the group of branched and unbranched hydrocarbons and waxes, the silicone oils, the dialkyl ethers, the group of saturated or unsaturated, branched or unbranched alcohols, and also the fatty acid triglycerides, especially the triglycerol esters saturated and / or ungung saturated, branched and / or unbranched alkane carboxylic acids with a chain length of 8 to 24, in particular 12-18 carbon atoms.
• the fatty acid triglycerides can, for example, advantageously be selected from the group of synthetic, semisynthetic and natural oils, for example olive oil, sunflower oil, soybean oil, peanut oil, rapeseed oil, almond oil, palm oil, coconut oil, palm kernel oil and the like. Any mixtures of such oil and wax components can also be used advantageously in the sense of the present invention.
• the O / W microemulsions according to the invention can also be obtained as microdispersions of solid wax particles.
• the oil phase is advantageously selected from the group consisting of 2-ethylhexyl isostearate, octyldodecanol, isotridecyl isononanoate, isoeicosane, 2-ethylhexyl cocoate, C 2 . 15 alkyl benzoate, caprylic capric acid triglyceride, dicaprylyl ether.
• hydrocarbons paraffinol, squalane and squalene can advantageously be used for the purposes of the present invention.
• the oil phase can advantageously also have a content of cyclic or linear silicone oils or consist entirely of such oils, although it is preferred to use an additional content of other oil phase components in addition to the silicone oil or the silicone oils.
• Cyclomethicone (octamethylcyclotetrasiloxane) is advantageously used as the silicone oil to be used according to the invention.
• other silicone oils can also be used advantageously for the purposes of the present invention, for example hexamethylcyclotrisiloxane, polydimethylsiloxane, poly (methylphenylsiloxane).
• Mixtures of cyclomethicone and isotridecyl isononanoate, of cyclomethicone and 2-ethylhexyl isostearate are also particularly advantageous.
• microemulsions according to the invention are advantageously prepared in such a way that a mixture of the basic components, including water phase, oil phase, one or more of the O / W emulsifiers according to the invention, if desired one or more W / O emulsifiers and, if desired, further auxiliaries, additives and / or active ingredients which form an O / W emulsion below the phase inversion temperature range, bring them to a temperature above or within the phase inversion temperature range, and subsequently bring the microemulsion to room temperature cools down. This is preferably done with stirring.
• An advantageous embodiment of the present invention is also considered to be a process for producing O / W microemulsions which comprise:
• a water phase if desired comprising customary water-soluble or dispersible substances,
• oil phase which is composed essentially of non-volatile constituents and which, if desired, comprises customary substances which are soluble or dispersible in the oil phase
• the initial concentration of the O / W emulsifier (s), which may also be zero, is selected and this or these O / W emulsifiers are added to the mixture obtained in (a)
• advantageous O / W microemulsions can be obtained if the proportion of the O / W emulsifier is below 20% by weight, in particular below 15% by weight, based on the total weight of the preparation, less than 5% by weight. an additional W / O emulsifier.
• phase inversion domain shows a very simplified representation of a phase diagram.
• the variable parameter P is plotted against the temperature ⁇ as a second variable.
• P represents a concentration parameter, either the proportion of the oil phase, the proportion of the water phase or the concentration of an emulsifier or an emulsifier mixture.
• O / W emulsion is present at lower temperatures and that the phase inversion range can be run through when the temperature is increased. As the temperature increases further, W / O emulsions are observed.
• the structure of the system in the phase inversion domain does not appear to be critical to the present invention. It is conceivable, for example, that in phase version range lamellar phases, bicontinuous phases, cubic, hexagonal or inverse hexagonal phases are present, also that the phase inversion range is composed of several identical or more or less different phases.
• the phase inversion range can be represented mathematically as a point set within the rectilinear coordinate system ⁇ , which is formed by the temperature, the concentration of a suitable emulsifier or a mixture of emulsifiers in the preparation, and the respective concentrations of the oil phase and the water phase, according to:
• ⁇ ⁇ O, ⁇ , m, H, W ⁇ , with O coordinate origin ⁇ - temperature m - concentration of the emulsifier / emulsifier mixture
• the phase inversion range ⁇ represents a connected area or a large number of connected areas within the coordinate system ⁇ .
• ⁇ represents the total set of coordinate points K ( ⁇ , a, mi, m 2 , .... m "H , W), which mixtures according to the invention from the water phase of the concentration W, oil phase of the concentration H, i emulsifiers according to the invention of the concentration m, determine at the temperature ⁇ , and for which applies that in the transition from a coordinate K-, € ⁇ to a coordinate K 2 e ⁇ phase inversion occurs, as described in FIG. 2.
• phase inversion range of a given system represents a single coherent (i + 3) -dimensional area or consists of several related but separate such areas, i.e. several corresponding phase inversion areas of a given system.
• the general term “the” or “one” phase inversion area is always used, even if two or more such separate areas are present.
• the practice of producing a microemulsion according to the invention accordingly advantageously consists in selecting one or more O / W emulsifiers used in accordance with the invention after the selection of suitable raw materials, ie water and oil phases, the latter or the latter in concentrations at which phase inversion is possible for the given mixture and, if appropriate, further substances which add the individual components together while stirring, bring about phase inversion by increasing the temperature of the mixture, after which the mixture is allowed to cool to room temperature with constant stirring.
• the concentration of the water phase is plotted against the temperature.
• the coordinates K 2 « ⁇ and K «or K 3 e ⁇ can be achieved by increasing the temperature while maintaining all other parameters.
• the coordinates K 3 and K4 lowering the temperature, while maintaining all other parameters, back to the coordinate K, O / W microemulsions according to the invention can be obtained.
• the coordinates K 5 can be achieved and O / W microemulsions according to the invention can be obtained.
• an O / W microemulsion according to the invention must already be present, to a certain extent as a concentrate, which is then converted to an O / W microemulsion of a different composition according to the invention by dilution.
• This is preferably done with stirring.
• This method according to the invention is particularly well suited if heat-sensitive or volatile substances are to be incorporated into the O / W microemulsions according to the invention.
• this process which is to be carried out at relatively low temperatures, is energy-saving compared to conventional processes.
• the coordinate L 2 can of course also be achieved by cooling a system present in the coordinate L 3 .
• the coordinates L 2 and L 3 in which, for example, W / O emulsions can be present, differ in principle only in that the temperature assigned to L 3 is higher than any temperature that can be assigned to the phase inversion temperature range.
• a further advantageous embodiment of the process according to the invention accordingly consists in bringing the individual components to a temperature with stirring at which phase inversion is possible for the given mixture after the selection of suitable raw materials, ie water and oil phase and optionally further substances. and to bring about phase inversion by adding the O / W emulsifier or the O / W emulsifiers used according to the invention to the mixture, after which the mixture is allowed to cool to room temperature with constant stirring.
• the suitable temperature range within which a given mixture can undergo phase inversion is not beyond the ability of the person skilled in the art to determine, by simple experiments, the suitable temperature range within which a given mixture can undergo phase inversion.
• this temperature range is to be chosen between 70 and 95 ° C, in individual cases it can also be above or below. In practice it is possible and possibly even advantageous to exceed the temperature range which can be assigned to the phase inversion range when producing a microemulsion according to the invention, since this area is then necessarily passed through when cooling to room temperature.
• microemulsions according to the invention therefore advantageously contain electrolytes, in particular one or more salts with the following anions: chlorides, furthermore inorganic oxo-element anions, of which in particular sulfates, carbonates, phosphates, borates and aluminates.
• electrolytes based on organic anions can also be used advantageously, for example lactates, acetates, benzoates, propionates, tartrates, citrates and others. Comparable effects can also be achieved with ethylenediaminetetraacetic acid and its salts.
• Ammonium, alkylammonium, alkali metal, alkaline earth metal, magnesium, iron and zinc ions are preferably used as cations of the salts.
• electrolytes there is no need to mention that only physiologically acceptable electrolytes should be used in cosmetics.
• Special medical applications of the microemulsions according to the invention can, at least in principle, result in the use of electrolytes which should not be used without medical supervision.
• Potassium chloride, sodium chloride, magnesium sulfate, zinc sulfate and mixtures thereof are particularly preferred. Salt mixtures as they occur in the natural salt from the Dead Sea are also advantageous.
• the concentration of the electrolyte or electrolytes should be approximately 0.1-10.0% by weight, particularly advantageously approximately 0.3-8.0% by weight, based on the total weight of the preparation.
• microemulsions according to the invention form the basis for cosmetic deodorants / antiperspirants
• all common active ingredients can be used advantageously, for example odor maskers such as the common perfume constituents, odor absorbers, for example the layered silicates described in patent application DE-P 40 09 347, of these in particular montmorillonite, kaolinite, llite, beidellite, nontronite, savonite, hectorite, bentonite, smectite, and furthermore, for example, zinc salts of ricinoleic acid.
• Germ-inhibiting agents are also suitable for incorporating into the microemulsions according to the invention. to be worked.
• advantageous substances are 2,4,4'-trichloro-2'-hydroxydiphenyl ether (irgasane), 1,6-di- (4-chlorophenylbiguanido) hexane (chlorhexidine), 3,4,4'-trichlorocarbanilide, quaternary ammonium compounds, clove oil, mint oil, thyme oil, triethyl citrate, farnesol (3,7,11.trimethyl-2,6,10-dodecatrien-1-ol) as well as those in the patent publications DE-37 40 186, DE- 39 38 140, DE-42 04 321, DE-42 29 707, DE-42 29 737, DE-42 37 081, DE-43 09 372, DE-43 24 219 described effective agents.
• irgasane 1,6-di- (4-chlorophenylbiguanido) hexane
• chlorhexidine 1,6-di- (4-chlorophenylbiguanido) he
• customary antiperspirant active ingredients can likewise advantageously be used in the microemulsions according to the invention, in particular astringents, for example basic aluminum chlorides.
• the cosmetic deodorants according to the invention can be in the form of aerosols, that is to say from aerosol containers, squeeze bottles or preparations sprayable by a pump device, or in the form of liquid compositions which can be applied by means of roll-on devices, but also in the form of microemulsions which can be applied from normal bottles and containers .
• Suitable blowing agents for cosmetic deodorants according to the invention which can be sprayed from aerosol containers are the customary, known volatile, liquefied blowing agents, for example hydrocarbons (propane, butane, isobutane) which can be used alone or in a mixture with one another. Compressed air can also be used advantageously.
• hydrocarbons propane, butane, isobutane
• the O / W microemulsions according to the invention are sprayed as aerosol droplets.
• Cosmetic and dermatological preparations which are in the form of a sunscreen are also favorable.
• these preferably additionally contain at least one UVA filter substance and / or at least one UVB filter substance and / or at least one inorganic pigment.
• UV-A or UV-B filter substances are usually incorporated into day creams.
• Preparations according to the invention can advantageously contain substances which absorb UV radiation in the UVB range, the total amount of filter substances e.g. 0.1% by weight to 30% by weight, preferably 0.5 to 10% by weight, in particular 1 to 6% by weight, based on the total weight of the preparations.
• the UVB filters can be oil-soluble or water-soluble.
• oil-soluble substances e.g. to call:
• 4-aminobenzoic acid derivatives preferably 4- (dimethylamino) benzoic acid (2-ethylhexyl) ester, 4- (dimethylamino) benzoic acid amyl ester;
• Esters of cinnamic acid preferably 4-methoxycinnamic acid (2-ethylhexyl) ester, 4-methoxycinnamic acid isopentyl ester;
• esters of salicylic acid preferably salicylic acid (2-ethylhexyl) ester, salicylic acid (4-isopropylbenzyl) ester, salicylic acid homomethyl ester;
• Esters of benzalmalonic acid preferably 4-methoxybenzalmalonic acid di (2-ethylhexyl) ester;
• Sulfonic acid derivatives of benzophenones preferably 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid and its salts;
• Sulfonic acid derivatives of 3-benzylidene camphor e.g. 4- (2-oxo-3-bornylidene-methyl) benzenesulfonic acid, 2-methyl-5- (2-oxo-3-bornylidene-methyl) sulfonic acid and their
• UVB filters which can be used according to the invention, is of course not intended to be limiting.
• the invention also relates to the combination of a UVA filter according to the invention with a UVB filter or a cosmetic or dermatological preparation according to the invention which also contains a UVB filter.
• UVA filters in preparations according to the invention, which are usually contained in cosmetic and / or dermatological preparations.
• Such substances are preferably derivatives of dibenzoylmethane, in particular 1- (4'-tert-butylphenyl) -3- (4'-methoxyphenyl) propane-1,3-dione and 1-phenyl-3- (4'-isopropylphenyl) propane-1,3-dione. Preparations containing these combinations are also the subject of the invention.
• the same amounts of UVA filter substances that were mentioned for UVB filter substances can be used.
• Cosmetic and / or dermatological preparations according to the invention can also contain inorganic pigments which are usually used in cosmetics to protect the skin from UV rays. These are oxides of titanium, zinc, iron, zirconium, silicon, manganese, aluminum, cerium and mixtures thereof, as well as modifications in which the oxides are the active agents. Particularly preferred are pigments based on titanium dioxide. The amounts given for the above combinations can be used.
• preparations according to the invention are very good vehicles for cosmetic or dermatological active ingredients in the skin, advantageous active ingredients being antioxidants which can protect the skin against oxidative stress.
• the preparations advantageously contain one or more antioxidants. All of the antioxidants suitable or customary for cosmetic and / or dermatological applications are used as inexpensive, but nevertheless optional antioxidants. It is advantageous to use antioxidants as the only class of active ingredient, for example when cosmetic or dermatological application is in the foreground, such as combating the oxidative stress on the skin. However, it is also favorable to provide the microemulsions according to the invention with a content of one or more antioxidants if the preparations are intended to serve another purpose, e.g. as deodorants or sunscreens.
• Amino acids eg histidine, tyrosine, tryptophan
• imidazoles eg urocanic acid
• peptides such as D, L-carnosine, D-carnosine, L-carnosine and their derivatives (eg anserine)
• carotenoids e.g. ⁇ -carotene, ß-carotene, lycopene
• lipoic acid and their derivatives e.g. dihydroliponic acid
• aurothioglucose propylthiouracil and other thiols
• thioredoxin glutathione, cysteine, cystine, cystamine and their glycosyl, N-acetyl -, Methyl, ethyl, propyl, amyl, butyl and lauryl, palmitoyl, oleyl, gamma-linoleyl, cholesteryl and glyceryl esters) and their salts, dilaurylthio dipropionate.
• buthioninsulfoximines homocysteine sulfoximine, buthionine sulfones, penta-, hexa-, hepthaninesulfoximine) in very low tolerable to dosages (for example pm) ⁇ mol / kg)
• metal chelators for example ⁇ -hydroxy fatty acids, ⁇ -hydroxypalmitic acid, phytic acid, lactoferrin
• -hydroxy acids for example citric acid, lactic acid, malic acid
• humic acid for example citric acid, lactic acid, malic acid
• bile acid bile extracts
• bilirubin biliverdin
• EDTA EGTA
• unsaturated saturated fatty acids and their derivatives e.g.
• Oil-soluble antioxidants can be used particularly advantageously for the purposes of the present invention.
• the amount of the antioxidants (one or more compounds) in the preparations is preferably 0.001 to 30% by weight, particularly preferably 0.05 to 20% by weight, in particular 1 to 10% by weight, based on the total weight of the preparation .
• vitamin E and / or its derivatives represent the antioxidant (s)
• vitamin A or vitamin A derivatives or carotenes or their derivatives represent the antioxidant or antioxidants, it is advantageous to use their respective concentrations in the range from 0.001-10% by weight, based on the total weight of the formulation, to choose.
• the customary auxiliaries and additives include, for example, consistency agents, fillers, perfume, dyes, emulsifiers, additional active ingredients such as vitamins or proteins, light stabilizers, stabilizers, insect repellents, alcohol, water, salts, antimicrobial, proteolytic or keratolytically active substances, etc.
• the water phase of the O / W microemulsions according to the invention can also contain thickeners, so that the overall preparation appears gel-like and is to be regarded as a microemulsion gel.
• Carragheenan or PEG-4-Rapeseedamide and Laureth-2 amide MEA for example, have proven to be suitable thickeners.
• active ingredients can also be selected very advantageously from the group of lipophilic active ingredients, in particular from the following group:
• unsaturated fatty acids in particular the essential fatty acids (often also called vitamin F), in particular gamma-linolenic acid, oleic acid, eicosapentaenoic acid, docosahexaenoic acid and its derivatives, chloramphenicol, caffeine, prostaglandins, thymol, camphor, Extracts or other products of plant and animal origin, such as evening primrose oil, borage oil or currant seed oil, fish oils, cod liver oil but also ceramides and ceramide-like compounds and so on.
• unsaturated fatty acids in particular the essential fatty acids (often also called vitamin F)
• the essential fatty acids in particular gamma-linolenic acid, oleic acid, eicosapentaenoic acid, docosahexaenoic acid and its derivatives
• chloramphenicol caffeine, prostaglandins, thymol, camphor, Extracts or other products of plant and animal origin,
• microemulsions according to the invention are of course also favored according to the invention, a further advantage of the microemulsions according to the invention is that the high number of finely divided droplets makes oil-soluble or lipophilic active substances, in particular, highly biologically available.
• the active substances from the group of refatting substances, for example purcellin oil, Eucerit and Neocerit.
• Aqueous cosmetic cleaning agents according to the invention or water-free or anhydrous cleaning agent concentrates intended for aqueous cleaning may contain cationic, anionic, nonionic and / or amphoteric surfactants, for example conventional soaps, for example fatty acid salts of sodium, alkyl sulfates, alkyl ether sulfates, alkane and alkylbenzenesulfonates, sulfoacetates , Sulfobetaines, sarcosinates, amidosulfobetanes, sulfosuccinates, sulfosuccinic acid semiesters, alkyl ether carboxylates, protein-fatty acid condensates, alkyl betaines and amidobetaones, fatty acid alkanolamides, polyglycol ether derivatives.
• conventional soaps for example fatty acid salts of sodium, alkyl sulfates, alkyl ether sulfates, al
• Cosmetic preparations which represent cosmetic cleansing preparations for the skin can be in liquid or semi-solid form, for example as gels. They preferably contain at least one anionic, cationic, non-ionic or amphoteric surface-active substance or mixtures thereof, optionally electrolytes and auxiliaries, as are usually used therefor.
• the surface-active substance can preferably be present in the cleaning preparations in a concentration of between 1 and 30% by weight, based on the total weight of the preparations.
• Cosmetic preparations which are a shampooing agent preferably contain at least one anionic, non-ionic or amphoteric surface-active substance or mixtures thereof, optionally electrolytes and auxiliaries, as are usually used therefor.
• the surface-active substance can preferably be present in the cleaning preparations in a concentration of between 1 and 50% by weight, based on the total weight of the preparations.
• cetyltrimethylammonium salts are advantageous to use.
• the preparations according to the invention intended for cleaning the hair or skin contain water and, if appropriate, the additives customary in cosmetics, for example perfume, thickeners, dyes, deodorants, antimicrobial substances, lipid-replenishing agents, complexing agents and sequestrants - agents, pearlescent agents, plant extracts, vitamins, active ingredients and the like.
• the additives customary in cosmetics for example perfume, thickeners, dyes, deodorants, antimicrobial substances, lipid-replenishing agents, complexing agents and sequestrants - agents, pearlescent agents, plant extracts, vitamins, active ingredients and the like.
• the preparations according to the invention surprisingly have very good foaming, high cleaning power and have a highly regenerative effect on the general skin condition.
• the preparations according to the invention have a skin-smoothing effect, reduce the feeling of dryness of the skin and make the skin supple.
• microemulsions according to the invention can contain the usual constituents, usually for example film-forming polymers.
• film formers are preferably those which are selected from the group of substances which, according to the INCI nomenclature (International Nomenclature Cosmetic Ingredient) has the name " Wear polyquaterniu ⁇ V, for example: Polyquaternium-2 (Chemical Abstracts No. 63451-27-4, e.g. Mirapol® A-15) Polyquaternium-5 (copolymer of the acrylamide and the ß-methacryloxyethyltrimethylammonium methosulfate, CAS No. 26006-22-4)
• Polyquaternium-6 (homopolymer of N, N-dimethyl-N-2-propenyl-2-propen-1-aminium chloride, CAS No. 26062-79-3, e.g. Merquat® 100
• Polyquaternium-17 CAS-No. 90624-75-2 e.g. Mirapol® AD-1 polyquaternium-19 quaternized water-soluble polyvinyl alcohol polyquaternium-20 water-dispersible quaternized polyvinyl octadecyl ether polyquaternium-21 polysiloxane-polydimethyl-dimethylammonium acetate copolymer, e.g. Abil® B 9905
• Polyquaternium-28 vinyl pyrrolidone ethacrylamidopropyltrimethylammonium chloride copolymer e.g. Gafquat® HS-100
• Polyquaternium-29 e.g. Lexquat® CH Polyquaternium-31 CAS no. 136505-02-7, e.g. Hypan® QT 100 Polyquaternium-32 N, N, N-trimethyl-2 - [(2-methyl-1-oxo-2-propenyl) oxy] -ethanaminium chloride, polymer with 2-propenamide, CAS no. 35429-19-7
• Preparations according to the invention for hair care advantageously contain 0.01-5% by weight of one or more film formers, preferably 0.1-3% by weight, in particular 0.2-2% by weight, - 36 -
• preparations according to the invention care for hair damaged or damaged by environmental influences or prevent such environmental influences. Furthermore, the preparations according to the invention impart loose fullness and strength to the hairstyle without being tacky.
• the preparations according to the invention can be used, for example, as a skin protection emulsion, cleansing milk, sun protection lotion, nutrient lotion, day or night emulsion, etc.
• microemulsions according to the invention also make an excellent contribution to smoothing the skin, in particular if they are provided with one or more substances which promote smoothing of the skin.
• preparations according to the invention may be possible and advantageous to use the preparations according to the invention as the basis for pharmaceutical formulations. Mutatis mutandis, corresponding requirements apply to the formulation of medical preparations.
• the transitions between pure cosmetics and pure pharmaceuticals are fluid.
• all classes of active substances are in principle geeginet as pharmaceutical active substances, lipophilic active substances being preferred. Examples are: antihistamines, antiphlogistics, antibiotics, antifungals, active substances that promote blood circulation, keratolytics, hormones, steroids, vitamins, etc.
• the cosmetic and dermatological preparations according to the invention can contain cosmetic auxiliaries as are usually used in such preparations, e.g. Preservatives, bactericides, virucides, perfumes, substances to prevent foaming, dyes, pigments that have a coloring effect, thickeners, surface-active substances, emulsifiers, softening, moisturizing and / or moisturizing substances, anti-inflammatory substances, medicines, fats, Oils, waxes or other usual components of a cosmetic or dermatological formulation such as alcohols, polyols, polymers, foam stabilizers, electrolytes, organic solvents.
• cosmetic auxiliaries e.g. Preservatives, bactericides, virucides, perfumes, substances to prevent foaming, dyes, pigments that have a coloring effect, thickeners, surface-active substances, emulsifiers, softening, moisturizing and / or moisturizing substances, anti-inflammatory substances, medicines, fats, Oils, waxes or other usual components of
• Fats, waxes and other natural and synthetic fat bodies preferably esters of fatty acids with alcohols of low C number, for example with isopropanol, propylene glycol or glycerol, or esters of fatty alcohols with alkanoic acids of low C number or with fatty acids
• alcohols can be used as further constituents , Diols or polyols of low C number, and their ethers, preferably ethanol, isopropanol, propylene glycol, glycerin, ethylene glycol, ethylene glycol monoethyl or monobutyl ether, propylene glycol monomethyl, - monoethyl or monobutyl ether, diethylene glycol monomethyl or monoethyl ether and similar products.
• the oil phase and the water phase are separately heated to 85-90 ° C., combined and cooled to room temperature with phase inversion, a transparent O / W microemulsion being formed.
• the oil phase and the water phase are separately heated to 85-90 ° C., combined and cooled to room temperature with phase inversion, a transparent O / W microemulsion being formed.
• Example 5 The oil phase and the water phase are separately heated to 85-90 ° C., combined and cooled to room temperature with phase inversion, a transparent O / W microemulsion being formed.
• Example 5 The oil phase and the water phase are separately heated to 85-90 ° C., combined and cooled to room temperature with phase inversion, a transparent O / W microemulsion being formed.
• the oil phase and the water phase are separately heated to 85-90 ° C., combined and cooled to room temperature with phase inversion, a transparent O / W microemulsion being formed.
• the oil phase and the water phase are separately heated to 85-90 ° C., combined and cooled to room temperature with phase inversion, a transparent O / W microemulsion being formed.
• the oil phase and the water phase are separately heated to 85-90 ° C., combined and cooled to room temperature with phase inversion, a transparent O / W microemulsion being formed.
• Example 11 The oil phase and the water phase are separately heated to 85-90 ° C., combined and cooled to room temperature with phase inversion, a transparent O / W microemulsion being formed.
• Example 11 The oil phase and the water phase are separately heated to 85-90 ° C., combined and cooled to room temperature with phase inversion, a transparent O / W microemulsion being formed.
• the oil phase and the water phase are separately heated to 85-90 ° C., combined and cooled to room temperature with phase inversion, a transparent O / W microemulsion being formed.
• the oil phase and the water phase are separately heated to 85-90 ° C., combined and cooled to room temperature with phase inversion, a transparent O / W microemulsion being formed.
• Example 15 The oil phase and the water phase are separately heated to 85-90 ° C., combined and cooled to room temperature with phase inversion, a transparent O / W microemulsion being formed.
• Example 15 The oil phase and the water phase are separately heated to 85-90 ° C., combined and cooled to room temperature with phase inversion, a transparent O / W microemulsion being formed.
• the oil phase and the water phase are separately heated to 85-90 ° C., combined and cooled to room temperature with phase inversion, a transparent O / W microemulsion being formed.
• the oil phase and the water phase are separately heated to 85-90 ° C., combined and cooled to room temperature with phase inversion, a transparent O / W microemulsion being formed.
• the oil phase and the water phase are separately heated to 85-90 ° C., combined and cooled to room temperature with phase inversion, a transparent O / W microemulsion being formed.
• Example 21 The oil phase and the water phase are separately heated to 85-90 ° C., combined and cooled to room temperature with phase inversion, a transparent O / W microemulsion being formed.
• Example 21 The oil phase and the water phase are separately heated to 85-90 ° C., combined and cooled to room temperature with phase inversion, a transparent O / W microemulsion being formed.
• the oil phase and the water phase are heated separately to 85-90 ° C., combined and cooled to room temperature with phase inversion, a transparent O / W microemulsion being formed.
• the oil phase and the water phase are separately heated to 85-90 ° C., combined and cooled to room temperature with phase inversion, a transparent O / W microemulsion being formed.

Landscapes

• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• General Health & Medical Sciences (AREA)
• Veterinary Medicine (AREA)
• Public Health (AREA)
• Chemical & Material Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• Epidemiology (AREA)
• Birds (AREA)
• Dispersion Chemistry (AREA)
• Oil, Petroleum & Natural Gas (AREA)
• Emergency Medicine (AREA)
• Biophysics (AREA)
• Molecular Biology (AREA)
• Medicinal Chemistry (AREA)
• Pharmacology & Pharmacy (AREA)
• Cosmetics (AREA)
• Medicinal Preparation (AREA)

Applications Claiming Priority (3)

Publications (1)

Family

ID=7756576

Family Applications (2)

Family Applications After (1)

Country Status (7)

Families Citing this family (76)

Family Cites Families (13)

• 1995
  • 1995-03-15 DE DE19509079A patent/DE19509079A1/de not_active Ceased
• 1996
  • 1996-03-07 JP JP8527247A patent/JPH11501641A/ja not_active Ceased
  • 1996-03-07 EP EP96907378A patent/EP0814752A2/fr not_active Ceased
  • 1996-03-07 WO PCT/EP1996/000968 patent/WO1996028131A2/fr not_active Application Discontinuation
  • 1996-03-14 JP JP8527280A patent/JPH11501645A/ja not_active Ceased
  • 1996-03-14 ES ES96907466T patent/ES2185766T3/es not_active Expired - Lifetime
  • 1996-03-14 WO PCT/EP1996/001088 patent/WO1996028132A2/fr not_active Application Discontinuation
  • 1996-03-14 DE DE59609870T patent/DE59609870D1/de not_active Revoked
  • 1996-03-14 AT AT96907466T patent/ATE227556T1/de not_active IP Right Cessation
  • 1996-03-14 US US08/930,404 patent/US6607733B1/en not_active Expired - Fee Related
  • 1996-03-14 EP EP96907466A patent/EP0814753B1/fr not_active Revoked

Non-Patent Citations (1)

Also Published As

Similar Documents

Legal Events